A Retrospective Analysis of AngioVac Outcomes at a Tertiary Care Center.

ABSTRACT:

Background

The AngioVac system is a vacuum aspiration device approved for removal of right-sided cardiac thrombi. It has also been used for management of right-sided endocarditis in selected cases. Retrospective case series have reported high success rate and acceptable 30-day mortality, but there is limited data regarding outcomes beyond the immediate postoperative period. The purpose of this study is to describe our institution's experience with the AngioVac system for thrombus, vegetation, and tumor removal with a significant improvement over previously reported 1-year survival rates.

Methods

A retrospective review of AngioVac cases performed at our tertiary care center from 2016-2022 was done. From 2016-2022, 23 patients were identified, and their outcomes are described.

SUBMITTER: Mullins JB 

PROVIDER: S-EPMC11308241 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature